MAY 19, 2022 3:00 PM PDT

Repurposed Antibiotic Shows Promise Against COVID-19 in Mice

WRITTEN BY: Annie Lennon

An antibiotic known as clofoctol has shown promise in treating SARS-CoV-2 in mice. The corresponding study was published in PLOS Pathogens by researchers from the University of Lille in France.  

Although COVID-19 vaccines may reduce hospitalizations and deaths from COVID-19, methods to reduce viral transmission that are affordable and effective are lacking. Already, researchers have tried to repurpose existing drugs for COVID-19, including remdesivir, hydroxychloroquine, and ribavirin. However, their efficacy has often been limited and, at times, controversial. 

Nevertheless, as repurposing existing drugs to treat COVID-19 shortens regulatory development steps, researchers have not given up the search for possibilities. In the current study, researchers analyzed the Apteeus drug library, a collection of 1,942 approved drugs, to identify molecules that could inhibit SARS-CoV-2 viral activity. Of the compounds examined, 21 exhibited substantial antiviral activity.

Of these compounds, they decided to further investigate an antibacterial drug known as clofoctol, currently used to treat bacterial respiratory tract infections, due to its favorable safety profile and pharmacokinetic properties. 

They thus tested the drug on mouse models of COVID-19. In doing so, they noted that clofoctol decreased viral load, reduced inflammatory gene expression, and lowered pulmonary pathology. 

"The antiviral and anti-inflammatory properties of clofoctol, associated with its safety profile and unique pharmacokinetics, make a strong case for proposing clofoctol as an affordable therapeutic candidate for the treatment of COVID-19 patients. Finally, the relatively low cost of this drug suggests that it is a potential clinical option for treatment of COVID-19 patients in resource-poor settings,” wrote the researchers. 

They say, however, that future studies are needed to see whether these results translate over to humans too. They also note that the mice were euthanized two days after treatment, meaning that further animal studies may also be needed to observe any long-term effects.


Sources: PLOS Pathogens, Frontiers in Immunology, Science Daily

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 20, 2022
Microbiology
Rapid AST: A key weapon in the fight against AMR
APR 20, 2022
Rapid AST: A key weapon in the fight against AMR
Despite the dire, well-documented risks of antimicrobial resistance (AMR), which threatens to kill 10 million people a y ...
APR 16, 2022
Neuroscience
A New Approach to Seizure Treatment
APR 16, 2022
A New Approach to Seizure Treatment
There are many types of epilepsy, a brain disorder that causes recurrent seizures or periods of altered behaviors or sen ...
APR 21, 2022
Drug Discovery & Development
Antidepressants and Anti-epileptics During Pregnancy May Affect Infant Brain Development
APR 21, 2022
Antidepressants and Anti-epileptics During Pregnancy May Affect Infant Brain Development
Fetal exposure to a mother's antiepileptic or antidepressant medication may affect infant brain development. The cor ...
JUN 06, 2022
Drug Discovery & Development
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
JUN 06, 2022
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific sat down with Sheng Li, PhD, Program Manager, to speak about our rapid service for small-scal ...
JUN 04, 2022
Drug Discovery & Development
Antibiotics Reduce Motivation to Exercise in Mice
JUN 04, 2022
Antibiotics Reduce Motivation to Exercise in Mice
Antibiotics may decrease athletes' motivation and endurance via effects on the microbiome. The corresponding study w ...
JUN 04, 2022
Drug Discovery & Development
3g of Omega-3 Fatty Acids Daily May Lower Blood Pressure
JUN 04, 2022
3g of Omega-3 Fatty Acids Daily May Lower Blood Pressure
Around 3g of omega-3 fatty acids taken on a daily basis may be the optimal dose for lowering blood pressure. The corresp ...
Loading Comments...